🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

146,73 USD

Máx. histórico

156,45

73 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-6,21%

Rango 52 semanas

85,24 – 156,92

Variación hoy

-0,14%

Cierre anterior

146,94

Rango de hoy

142,80 – 147,48

Volumen hoy

7.462.267

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,43%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
148,21 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
161,53 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 1 hora
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,32%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
20/12/2018 70,09 70,73 69,31 70,12 -0,38% 2,03% 20.321.454
19/12/2018 71,26 71,80 69,72 70,39 -0,75% 2,92% 19.765.594
18/12/2018 72,14 72,31 70,19 70,93 -1,20% 2,94% 16.163.828
17/12/2018 72,49 73,37 71,43 71,78 -1,63% 2,67% 15.831.822
14/12/2018 74,27 74,46 72,74 72,98 -3,20% 2,31% 13.896.375
13/12/2018 74,67 75,46 74,43 75,39 +1,28% 1,38% 11.272.498
12/12/2018 74,21 75,15 74,16 74,44 +1,17% 1,34% 11.219.678
11/12/2018 74,35 74,72 73,03 73,58 -0,40% 2,27% 13.867.660
10/12/2018 73,90 74,22 72,39 73,87 +0,91% 2,48% 16.163.618
07/12/2018 74,64 74,71 72,61 73,21 -2,11% 2,81% 13.228.799
06/12/2018 73,44 74,78 72,35 74,78 +0,20% 3,31% 17.329.518
04/12/2018 75,67 76,52 74,52 74,63 -1,27% 2,64% 15.482.942
03/12/2018 75,88 75,94 74,69 75,59 -0,15% 1,63% 13.183.106
30/11/2018 74,27 75,85 74,16 75,71 +1,84% 2,27% 22.380.669
29/11/2018 73,65 74,89 73,58 74,34 +0,88% 1,77% 11.429.174
28/11/2018 73,28 73,82 72,78 73,69 +1,17% 1,42% 12.625.675
27/11/2018 71,63 73,02 71,63 72,84 +1,19% 1,93% 15.325.533
26/11/2018 71,56 72,28 71,36 71,98 +1,03% 1,28% 11.407.061
23/11/2018 70,73 71,85 70,62 71,25 -0,16% 1,74% 3.690.846
21/11/2018 71,49 71,63 70,78 71,36 +0,01% 1,19% 9.489.116
20/11/2018 72,53 72,86 71,23 71,36 -2,06% 2,25% 14.240.014
19/11/2018 72,73 73,10 72,13 72,85 +0,38% 1,34% 17.210.675
16/11/2018 71,32 72,76 71,14 72,58 +1,63% 2,27% 14.384.010
15/11/2018 70,13 71,44 69,78 71,41 +1,01% 2,37% 12.549.171
14/11/2018 71,52 71,53 70,31 70,70 -0,70% 1,71% 9.936.193
13/11/2018 71,77 71,82 70,62 71,19 -0,11% 1,68% 16.587.430
12/11/2018 71,69 71,82 70,64 71,27 -0,23% 1,65% 14.679.022
09/11/2018 72,39 72,51 71,37 71,43 -0,82% 1,57% 15.359.802
08/11/2018 71,46 72,22 71,20 72,02 +0,53% 1,43% 13.634.690
07/11/2018 70,71 71,88 70,46 71,64 +2,41% 2,01% 19.566.684